LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer-Reference-Cited by-同舟云学术

LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer

Published:2023-04 Issue: Volume:860 Page:147227
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

He Yongyin,Xiao Bin,Lei Ting,Xuan Junfeng,Zhu Yi,Kuang Zhenzhan,Liu Jiahui,He Jia,Li Linhai,Sun Zhaohui

Funder

National Natural Science Foundation of China-Guangdong Joint Fund

China People's Liberation Army General Logistics Department

Natural Science Foundation of Guangdong Province

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference44 articles.

1. Identification of potential serum biomarkers for breast cancer using a functional proteomics technology;Wang;Biomarker Res.,2017

2. A micropeptide XBP1SBM encoded by lncRNA promotes angiogenesis and metastasis of TNBC via XBP1s pathway;Wu;Oncogene,2022

3. LncRNA Uc003xsl.1-Mediated Activation of the NFκB/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer;Xu;Cancer Res.,2022

4. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer;Lin;Mol. Cancer,2018

5. Evaluation of C5orf66-AS1 as a Potential Biomarker for Predicting Early Gastric Cancer and Its Role in Gastric Carcinogenesis;Zhou;OncoTargets and therapy,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the code: the pivotal role of lncRNAs in advancing TNBC therapy;Frontiers in Oncology;2024-09-02

2. LncRNA-MUF: A Novel Oncogenic Star with Potential as a Biological Marker and Therapeutic Target for Gastrointestinal Malignancies;Journal of Cancer;2024

3. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer;Journal of Zhejiang University-SCIENCE B;2023-12

4. Role of long non-coding RNAs and TGF-β signaling in the regulation of breast cancer pathogenesis and therapeutic targets;Cytokine;2023-10

5. PD-1/PD-L1 Inhibitors Response in Triple-Negative Breast Cancer: Can Long Noncoding RNAs Be Associated?;Cancers;2023-09-22